Iovance Biotherapeutics: High-Risk Cancer Stock Potential
A bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
Explore which risk parity funds are retirement friendly and fit conservative to balanced retirement goals. A quick guide to evaluating suitability.
27,924 articlesA bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
Garmin delivered a dominant Q4 with a big EPS beat and revenue surge, triggering a sharp market rally as investors we...
A broad rally in semiconductor stocks persists into late May 2026, driven by AI infrastructure demand. Yet history ca...
Berkshire Hathaway's July 2026 moves reveal a rotating bet toward cash-generating, earnings-ready names. Delta Air Li...
Institutions are back in force for Bitcoin, led by US Bitcoin ETFs and MicroStrategy buying. Flows total about $1.25B...
A shift away from 1% AUM fees is accelerating in 2026 as markets mature and tech-enabled portfolios reduce manual wor...
Berkshire Hathaway has quietly built a near-10% stake in Domino’s Pizza, signaling a long-term, cash-flow driven thes...
Duke University researchers unveiled Argus, a 20-legged robot capable of moving in any direction. The breakthrough co...
A careful look at tariffs shows they often translate into higher checkout prices for everyday items. This article bre...
A trio of ETFs focusing on nuclear and uranium stocks is catching investor attention as AI computing expands. The cas...
Interloom just raised $16.5 million to convert tacit knowledge into AI-driven workflow tools. The Munich startup says...
A simple, unfiltered morning skincare video from Jennifer Lopez coincides with the premiere of a new Netflix romance....